... developed approach called, Cancer Outlier Profile Analysis (COPA), that identifies outlier oncogenes in a specific subset of cancer cases. Using this methodology to examine data from seven prostate ...
... culprit. To prove it, he and his colleagues started by deleting the promoter region of the c-myc oncogene, rendering the gene inactive, in a mutant line of mice. By looking for — and not finding — ...
... survival.
Mutations in the RAF kinase B-RAF have been found in many types of human cancer but, while oncogenic B-RAF V600E has been linked with tumor induction, growth, maintenance and progression, ...
... GP130 in 60% of IHCA (Rebouissou et al, Nature, 2009), thus defining GP130 as a new oncogene in human tumours. This study aimed to evaluate frequency of GP130 mutations in a wide series of tumours.
...
DLX5, a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers from Fox Chase Cancer Center. Since the DLX5 gene is ...
... , a gene crucial for embryonic development, promotes cancer by activating the expression of the known oncogene, MYC, according to researchers. Since the DLX5 gene is inactive in normal adults, it may ...
Scientists at the Mayo Clinic campus in Florida have found that the lung cancer oncogene PKCiota is necessary for the proliferation of lung cancer stem cells. These stem cells are rare and powerful ...
... , in function of the tissue that is affected, Notch can serve as a “tumor suppressor” or as an oncogene. The conclusions drawn from this study, point to effectors being regulated by this pathway. “We ...
... a new gene that causes cancer. The ground-breaking research appears in Nature’s cancer journal Oncogene. The gene and its protein, both called RBM3, are vital for cell division in normal cells. In ...
Researchers at the Oklahoma University Cancer Institute have identified a new gene that causes cancer. The ground-breaking research appears Monday in Nature’s cancer journal Oncogene.
read more
... , but it springs into action in response to DNA damage or activation of cancer-promoting genes, or oncogenes.
Lozano, an expert on mouse models of human cancer, and colleagues developed mice with a ...
... is an antiproliferative program that is initiated by tumor suppressors in response to oncogenic activation of hyperproliferation.
“Our working hypothesis is that aberrant accumulation of IRS-1, ...
... began testing, at the genomic scale, a prediction that genes responding synergistically to cooperating oncogenic mutations might act as the “drivers” toward malignancy, Land said. It now appears that ...
... showed that these malignancies occur after an androgen (male hormone)-dependent gene fuses with an oncogene -- a type of gene that causes cancer," he explains.
Experts have long understood that male ...
... their post-remission therapy.
"This appears to be the first example in AML of a mutation in an oncogene that favorably modifies a patient's response to the dose of a routinely used chemotherapeutic ...
